MMP9 and metastatic malignant neoplasm: On the other hand, 5-FU (an antimetabolite inhibiting DNA replication) more effectively combated the tumor growth of mCRC, although MMP9 positive metastatic cancer cells remained even after the 5-FU treatment, which was thought to be insensitive, dormant cancer cells in the tumoroids.